SWOG clinical trial number
SWOG-7703

RT in Combination with BCNU, Dimethyl Triazeno Imidazole Carboxamide (DTIC) or Procargazine in Patients with Malignant Gliomas of the Brain

Closed
Phase
Published
Abbreviated Title
RT in Combination with BCNU, Dimethyl Triazeno Imidazole Carboxamide (DTIC) or Procargazine in Patients with Malignant Gliomas of the Brain
Activated
03/07/1977
Closed
07/28/1981

Publication Information Expand/Collapse

1994

Prognostic variables in anaplastic astrocytoma.

CP Harris;JJ Townsend;KA Jaeckle;C Upchurch;HJ Eyre Neurology 44(Suppl.2):A309(#723P)

1989

A retrospective comparison of high dose BCNU with autologous marrow rescue plus radiotherapy vs. IV BCNU plus radiation therapy in high grade gliomas: A Southwest Oncology Group review.

W Goodwin;J Crowley ASCO 8:90(#352)

1986

Randomized comparisons of radiotherapy and carmustine versusprocarbazine versus dacarbazine for the treatment of malignant gliomasfollowing surgery: A Southwest Oncology Group study.

HJ Eyre;JR Eltringham;EA Gehan;FS Vogel;M Al-Surraf;RW Talley;JJ Costanzi;JW Athens;N Oishi;WS Fletcher Cancer Treat Rep 7(9):1085-1090

1982

Malignant glioma: A randomized trial of radiotherapy plus BCNU, Procarbazine, or DTIC: A Southwest Oncology Group study.

HJ Eyre;JM Quagliana;DM Lane;J Frank;FS Vogel ASCO, #C-701